Shi Zhi-Feng, Li Kay Ka-Wai, Liu Anthony Pak-Yin, Chung Nellie Yuk-Fei, Wong Sze-Ching, Chen Hong, Woo Peter Yat-Ming, Chan Danny Tat-Ming, Mao Ying, Ng Ho-Keung
Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai 200040, China.
Hong Kong and Shanghai Brain Consortium (HSBC), Hong Kong, China.
Cancers (Basel). 2024 Apr 29;16(9):1740. doi: 10.3390/cancers16091740.
Pediatric brain tumors are often noted to be different from their adult counterparts in terms of molecular features. Primary CNS lymphomas (PCNSLs) are mostly found in elderly adults and are uncommon in children and teenagers. There has only been scanty information about the molecular features of PCNSLs at a young age. We examined PCNSLs in 34 young patients aged between 7 and 39 years for gene rearrangements of BCl2, BCL6, CCND1, IRF4, IGH, IGL, IGK, and MYC, homozygous deletions (HD) of CDKN2A, and HLA by FISH. Sequencing was performed using WES, panel target sequencing, or Sanger sequencing due to the small amount of available tissues. The median OS was 97.5 months and longer than that for older patients with PCNSLs. Overall, only 14 instances of gene rearrangement were found (5%), and patients with any gene rearrangement were significantly older ( = 0.029). CDKN2A HD was associated with a shorter OS ( < 0.001). Only 10/31 (32%) showed MYD88 mutations, which were not prognostically significant, and only three of them were L265P mutations. CARD11 mutations were found in 8/24 (33%) cases only. Immunophenotypically, the cases were predominantly GCB, in contrast to older adults (61%). In summary, we showed that molecular findings identified in the PCNSLs of the older patients were only sparingly present in pediatric and young adult patients.
小儿脑肿瘤在分子特征方面通常被认为与成人脑肿瘤不同。原发性中枢神经系统淋巴瘤(PCNSLs)大多见于老年人,在儿童和青少年中并不常见。关于年轻患者PCNSLs分子特征的信息非常有限。我们对34例年龄在7至39岁之间的年轻患者的PCNSLs进行了检测,通过荧光原位杂交(FISH)检测BCl2、BCL6、CCND1、IRF4、IGH、IGL、IGK和MYC的基因重排、CDKN2A的纯合缺失(HD)以及HLA。由于可用组织量少,使用全外显子测序(WES)、靶向测序或桑格测序进行测序。中位总生存期为97.5个月,比老年PCNSLs患者的生存期更长。总体而言,仅发现14例基因重排(5%),有任何基因重排的患者年龄显著更大(P = 0.029)。CDKN2A HD与较短的总生存期相关(P < 0.001)。仅10/31(32%)显示MYD88突变,这些突变在预后方面无显著意义,其中只有3个是L265P突变。仅在8/24(33%)的病例中发现CARD11突变。免疫表型方面,与老年患者(61%)相比,这些病例主要为生发中心B细胞(GCB)型。总之,我们表明在老年患者PCNSLs中发现的分子特征在儿童和年轻成人患者中仅少量存在。